Syngenta Group’s planned 65 billion yuan ($9.26 billion) initial public offering, potentially the world’s biggest this year, is expected to boost foreign fund interest in China’s onshore equities market.
This content was published on
2 minutes
Bloomberg/ac
The Switzerland-based seed giant had its listing application accepted on Friday to move ahead with an offering on the main board of the Shanghai Stock Exchange. Its Chinese owner is resuming a plan that stalled in March after the bourse abruptly canceled a hearing for a debut on the smaller, tech-focused Star Board.
Shifting Syngenta’s IPO to the main board “makes sense as it provides access to a more mature market and larger liquidity base,” said Ben Harburg, managing partner at Magic Stone Alternative Investment Ltd. in Beijing. The listing of the Swiss firm matches China’s drive to attract capital through regulatory improvements and investment vehicles such as qualified foreign investors, he added.
Traditionally, IPOs on Chinese exchanges have been mostly focused on domestic investors, which also has limited the potential investment pool. Sinochem Holdings Corp., a Chinese state-owned company and Syngenta’s owner, had discussed a potential reduction in the fundraising size with Chinese authorities to mollify concerns that a large offering could put pressure on liquidity in the market, Bloomberg reported last month.
“The case is intriguing and all eyes are on the SHEX’s approval process and the success of the IPO,” said Jason Hsu, chief investment officer at Rayliant Global Advisors Ltd. “SHEX and Beijing want to see a success story here. Beijing wants more global firms to list on Chinese stock exchanges. This will further legitimize China as a viable money center.”
Listings onshore last year raised more proceeds than in any other country. While the pace of offerings has slowed in 2023, with $26.9 billion raised year-to-date, the amount is still higher than the combined tally for listings in the US, Hong Kong, Europe and Japan.
China has been working on simplifying fundraising from equity sales in the nation’s market. Earlier this year, it expanded a registration-based system for listings on all exchanges beyond the Star Board. The move shortened review periods, and gave exchanges responsibility for vetting the eligibility of IPO candidates. It also made the listing process quicker and simpler, drawing closer to practices in foreign markets.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
This content was published on
Syngenta’s board voted unanimously to accept the offer, which will be finalised by the end of 2016. SyngentaExternal link said on Wednesday the move would allow it to make long-term investments in innovation. Syngenta’s current management will continue to lead the company. After the transaction is finalised, a board of directors composed of six members…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.